This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Gammadelta Therapeutics Ltd. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Afonso Rocha Martins De Almeida: Innovator in T Cell Production
Introduction
Afonso Rocha Martins De Almeida is a notable inventor based in Cantanhede, Portugal. He has made significant contributions to the field of immunology, particularly in the production of TCR gamma delta + T cells. With a total of two patents to his name, his work has implications for clinical applications in cell therapy.
Latest Patents
Afonso's latest patents focus on novel methods for the isolation and selective ex vivo expansion of V32' TCRy6+ T cells. These inventions aim to enhance the clinical application of these specialized T cells, which play a crucial role in immune response.
Career Highlights
Throughout his career, Afonso has worked with prominent companies in the biotechnology sector, including Gammadelta Therapeutics Ltd and Lymphact—Lymphocyte Activation Technologies, S.A. His expertise in T cell production has positioned him as a key figure in advancing therapeutic techniques.
Collaborations
Afonso has collaborated with notable professionals in his field, including Diogo Antonio Remechido Anjos and Daniel Vargas Correia. These partnerships have contributed to the development and refinement of his innovative methods.
Conclusion
Afonso Rocha Martins De Almeida is a distinguished inventor whose work in T cell production is paving the way for advancements in immunotherapy. His patents and collaborations reflect his commitment to enhancing clinical applications in this vital area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile